Correlation Between Mach7 Technologies and Genetic Technologies
Can any of the company-specific risk be diversified away by investing in both Mach7 Technologies and Genetic Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mach7 Technologies and Genetic Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mach7 Technologies and Genetic Technologies, you can compare the effects of market volatilities on Mach7 Technologies and Genetic Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mach7 Technologies with a short position of Genetic Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mach7 Technologies and Genetic Technologies.
Diversification Opportunities for Mach7 Technologies and Genetic Technologies
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mach7 and Genetic is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Mach7 Technologies and Genetic Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genetic Technologies and Mach7 Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mach7 Technologies are associated (or correlated) with Genetic Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genetic Technologies has no effect on the direction of Mach7 Technologies i.e., Mach7 Technologies and Genetic Technologies go up and down completely randomly.
Pair Corralation between Mach7 Technologies and Genetic Technologies
Assuming the 90 days trading horizon Mach7 Technologies is expected to under-perform the Genetic Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Mach7 Technologies is 3.84 times less risky than Genetic Technologies. The stock trades about -0.02 of its potential returns per unit of risk. The Genetic Technologies is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 30.00 in Genetic Technologies on September 20, 2024 and sell it today you would lose (26.10) from holding Genetic Technologies or give up 87.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Mach7 Technologies vs. Genetic Technologies
Performance |
Timeline |
Mach7 Technologies |
Genetic Technologies |
Mach7 Technologies and Genetic Technologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mach7 Technologies and Genetic Technologies
The main advantage of trading using opposite Mach7 Technologies and Genetic Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mach7 Technologies position performs unexpectedly, Genetic Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genetic Technologies will offset losses from the drop in Genetic Technologies' long position.Mach7 Technologies vs. PVW Resources | Mach7 Technologies vs. Woolworths | Mach7 Technologies vs. Wesfarmers | Mach7 Technologies vs. Ramsay Health Care |
Genetic Technologies vs. Charter Hall Education | Genetic Technologies vs. TTG Fintech | Genetic Technologies vs. Mach7 Technologies | Genetic Technologies vs. Macquarie Technology Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |